Zomedica Media Sentiment
Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.
Media Coverage
We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.
Zomedica (NYSEAMERICAN ZOM) News Headlines Today
Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm.
What is Truforma used for?
Truforma is a point of care device meant to be used by veterinary doctors. The platform would help detect thyroid and adrenal diseases in pets, and many see it as a potentially game-changing product. Last month, Zomedica announced the first commercial sale of Truforma. Article continues below advertisement.
Is Zomedica a good company?
Zomedica is a niche company and is a good way to play the animal diagnostic market. According to Zomedica, nearly two-thirds of U.S. households have at least one pet and most of the households with a pet dog visit a veterinarian annually.
What is the IPO price of Zoom?
Think of it this way: Zoom is the poster child of the work from home movement. In April 2019, Zoom announced its IPO priced at $36 per share , which implied a market capitalization of approximately $9.2 billion. This year, Zoom’s stock has risen by 600%.
Why is Zoom growing?
Why has Zoom experienced explosive growth? The Covid-19 pandemic has fueled Zoom’s growth as more companies use Zoom’s platform for meetings and collaboration, while individuals use Zoom to stay in touch with friends and family. Social distancing rules and closed offices has led to a substantial increase in Zoom’s user base, financial performance and stock price.